DR. SONJA WALTRAUD SCHOLZ M.D., PH.D.
Prescription History 1982994695
Psychiatry & Neurology - Neurology in Baltimore, MD

NPI Status: Active since April 14, 2011

Contact Information

600 N WOLFE ST
BALTIMORE, MD
ZIP 21287
Phone: (240) 271-5297

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. SONJA WALTRAUD SCHOLZ M.D., PH.D., an active Neurology specialist practicing in Baltimore, MD. Our medical registry currently tracks 1 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 14 documented patient claims. Among these therapy options, the most frequently utilized medication is Donepezil Hcl, which accounts for 14 claims alone.

Medication Index

No matching medications currently found on file.

Donepezil Hcl

Generic Formulation: Donepezil HclSpecialty: Psychiatry & Neurology
Provider Metrics Summary
Total Claims 14
30-Day Fills 32.0
Days Supply 960
MD State Average Benchmarks
Peer Average Claims47.0
Peer Average 30-Day Fills81.5
Peer Average Days Supply2,365
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 70.2% less volume than the regional standard for practitioners inside MD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $187.07 across this reporting matrix range.

Provider Avg Cost Per Claim

$13.36

State Avg Cost Per Claim

$18.75

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Donepezil is used to treat confusion (dementia) related to Alzheimer's disease. It does not cure Alzheimer's disease, but it may improve memory, awareness, and the ability to function. This medication is an enzyme blocker that works by restoring the balance of natural substances (neurotransmitters) in the brain.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. SONJA WALTRAUD SCHOLZ M.D., PH.D. provides transparency into local medical care patterns within Baltimore, MD.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Neurology** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.